Patents by Inventor Patrik Zueger

Patrik Zueger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RAPAMYCIN DERIVATIVES
    Publication number: 20220064185
    Abstract: The disclosure provides 32-deoxo-rapamycin derivatives of Formula (I), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions and pharmaceutical combinations comprising a compound of Formula (I), and methods of making same. Also provided herein are methods of using a compound of Formula (I) or a pharmaceutically acceptable salt thereof for treating the diseases and disorders described herein.
    Type: Application
    Filed: December 17, 2019
    Publication date: March 3, 2022
    Inventors: Simone Bonazzi, Michael Connolly, David Jonathan Glass, Manuel Mihalic, Andrew W. Patterson, Silvio Roggo, Tea Shavlakadze, Patrik Zueger
  • Composition for treatment of pathogens that are resistant to tetracyclines
    Patent number: 9682079
    Abstract: The invention relates to compounds and pharmaceutical compositions useful in combination with tetracyclines in the treatment of bacterial infections caused by Gram-positive and Gram-negative pathogens, with particular efficacy in tetracycline resistant strains. These compounds specifically bind to TetR and therefore prevent the transcriptional activation of tet resistance genes. The compounds have a potentiating effect on the activity of members of the tetracycline family, in particular of tetracycline, minocycline, doxycycline and tigecycline, in the treatment of tetracycline susceptible, intermediate and tetracycline resistant pathogens.
    Type: Grant
    Filed: February 3, 2014
    Date of Patent: June 20, 2017
    Assignee: BIOVERSYS AG
    Inventors: Peter Schneider, Rainer Riedl, Marcel Tigges, Marc Gitzinger, Michel Pieren, Assaf Levi, Mark Sephton, Birgit Schellhorn, Patrik Zueger, Michael Brand, Daniel Gygax, Peter Spies
  • COMPOSITION FOR TREATMENT OF PATHOGENS THAT ARE RESISTANT TO TETRACYCLINES
    Publication number: 20150359791
    Abstract: The invention relates to compounds and pharmaceutical compositions useful in combination with tetracyclines in the treatment of bacterial infections caused by Gram-positive and Gram-negative pathogens, with particular efficacy in tetracycline resistant strains. These compounds specifically bind to TetR and therefore prevent the transcriptional activation of tet resistance genes. The compounds have a potentiating effect on the activity of members of the tetracycline family, in particular of tetracycline, minocycline, doxycycline and tigecycline, in the treatment of tetracycline susceptible, intermediate and tetracycline resistant pathogens.
    Type: Application
    Filed: February 3, 2014
    Publication date: December 17, 2015
    Inventors: Peter Schneider, Rainer Riedl, Marcel Tigges, Marc Gitzinger, Michel Pieren, Assaf Levi, Mark Sephton, Birgit Schellhorn, Patrik Zueger, Michael Brand, Daniel Gygax, Peter Spies